19754-80-4 Usage
General Description
(5-Ethylisoxazol-3-yl)amine, also known as isoxazole-5-yl-ethylamine, is a chemical compound with the molecular formula C5H9NO. It is classified as an isoxazole amine, which is a type of organic compound containing an isoxazole ring (a five-membered heterocyclic ring containing oxygen and nitrogen atoms) attached to an amine group. (5-Ethylisoxazol-3-yl)amine has potential applications in medicinal chemistry, particularly in the development of pharmaceutical drugs. It may also be used as a building block in organic synthesis to create more complex chemical compounds. The specific properties and uses of (5-Ethylisoxazol-3-yl)amine may vary depending on the context in which it is being employed.
Check Digit Verification of cas no
The CAS Registry Mumber 19754-80-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,7,5 and 4 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 19754-80:
(7*1)+(6*9)+(5*7)+(4*5)+(3*4)+(2*8)+(1*0)=144
144 % 10 = 4
So 19754-80-4 is a valid CAS Registry Number.
19754-80-4Relevant articles and documents
-
Haruki et al.
, p. 267 (1968)
-
HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS AS INHIBITORS OF BTK ACTIVITY
-
Paragraph 1189; 1190, (2015/11/16)
Heteroaryl pyridone and aza-pyridone compounds of Formula I are provided, where one or two of X, X, and Xare N, and including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I foranddiagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
QUINOLINE DERIVATIVES
-
Page/Page column 38, (2009/04/24)
The invention concerns quinoline derivatives of Formula I or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.
